Last updated: 16 June 2019 at 6:28pm EST

Sean E Harper Net Worth




The estimated Net Worth of Sean E Harper is at least $31.3 Million dollars as of 16 July 2018. Sean Harper owns over 1,525 units of AMGEN stock worth over $18,505,938 and over the last 13 years Sean sold AMGN stock worth over $12,803,603.

Sean Harper AMGN stock SEC Form 4 insiders trading

Sean has made over 16 trades of the AMGEN stock since 2012, according to the Form 4 filled with the SEC. Most recently Sean sold 1,525 units of AMGN stock worth $298,458 on 16 July 2018.

The largest trade Sean's ever made was exercising 39,900 units of AMGEN stock on 27 July 2012 worth over $2,730,357. On average, Sean trades about 2,712 units every 44 days since 2012. As of 16 July 2018 Sean still owns at least 56,082 units of AMGEN stock.

You can see the complete history of Sean Harper stock trades at the bottom of the page.



What's Sean Harper's mailing address?

Sean's mailing address filed with the SEC is ONE AMGEN CENTER DRIVE, , THOUSAND OAKS, CA, 91320-1799.

Insiders trading at AMGEN

Over the last 22 years, insiders at AMGEN have traded over $219,663,137 worth of AMGEN stock and bought 8,904 units worth $919,219 . The most active insiders traders include Robert Eckert, Kevin W Sharer, and Ellen Jamison Kullman. On average, AMGEN executives and independent directors trade stock every 35 days with the average trade being worth of $8,732,261. The most recent stock trade was executed by Nancy A. Grygiel on 3 May 2024, trading 2,117 units of AMGN stock currently worth $662,812.



What does AMGEN do?

Amgen Inc. is an American multinational biopharmaceutical company headquartered in Thousand Oaks, California. One of the worlds largest independent biotechnology companies, Amgen was established in Thousand Oaks, California, in 1980.



Complete history of Sean Harper stock trades at AMGEN

Insider
Trans.
Transaction
Total value
Sean E Harper
EVP, Research, and Development
Sale $298,458
16 Jul 2018
Sean E Harper
EVP, Research, and Development
Sale $281,012
12 Jun 2018
Sean E Harper
EVP, Research, and Development
Sale $265,503
14 May 2018
Sean E Harper
EVP, Research, and Development
Sale $263,337
12 Apr 2018
Sean E Harper
EVP, Research, and Development
Sale $289,369
16 Mar 2018
Sean E Harper
EVP, Research, and Development
Sale $265,625
14 Feb 2018
Sean E Harper
EVP, Research, and Development
Sale $283,071
16 Jan 2018
Sean E Harper
EVP, Research, and Development
Sale $269,666
12 Dec 2017
Sean E Harper
EVP, Research, and Development
Sale $261,660
13 Nov 2017
Sean E Harper
EVP, Research, and Development
Sale $283,574
9 Oct 2017
Sean E Harper
EVP, Research, and Development
Sale $3,456,031
29 Apr 2016
Sean E Harper
EVP, Research, and Development
Sale $4,804,240
22 Apr 2015
Sean E Harper
EVP, Research, and Development
Sale $1,782,060
5 Aug 2014
Sean E Harper
EVP, Research, and Development
Option $403,520
2 May 2013
Sean E Harper
EVP, Research, and Development
Option $2,730,357
27 Jul 2012
Sean E Harper
EVP, Research, and Development
Option $656,320
3 May 2012


AMGEN executives and stock owners

AMGEN executives and other stock owners filed with the SEC include: